The Radiopharmaceutical Theranostics Market Size is expanding rapidly due to increasing prevalence of cancer, neuroendocrine tumors, and cardiovascular diseases. Advanced molecular imaging and radioisotope therapies are enhancing clinical outcomes, fueling adoption in hospitals and specialized treatment centers. The growing emphasis on precision medicine and personalized therapy is driving...